Monitoring Breast Cancer Response to Neoadjuvant Systemic Chemotherapy Using Parametric Contrast-Enhanced MRI: A Pilot Study
Authors:
- Ming-Ting WuMWMing-Ting Wu
- Hong-Tai ChangHCHong-Tai Chang
- Yu-Shin LoYLYu-Shin Lo
- Huay-Ben PanHPHuay-Ben Pan
- Hadassa DeganiHDHadassa Degani
- Edna Furman-HaranEFEdna Furman-Haran
- 1 May 2007
- journal article
- Published by Elsevier in Academic Radiology
- Vol. 14 (5) , 561-573
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An UpdateJournal of Clinical Oncology, 2006
- Diagnostic Architectural and Dynamic Features at Breast MR Imaging: Multicenter StudyRadiology, 2006
- MRI in the detection and management of breast cancerExpert Review of Anticancer Therapy, 2005
- Accuracy of MRI in the Detection of Residual Breast Cancer After Neoadjuvant ChemotherapyAmerican Journal of Roentgenology, 2003
- Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapyEuropean Radiology, 2003
- Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRIBreast Cancer Research and Treatment, 2003
- Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapyEuropean Radiology, 2002
- MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast CancerAnnals of Surgical Oncology, 2001
- Contrast-enhanced magnetic resonance imaging of the breastEuropean Journal of Radiology, 2000
- MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations.Radiology, 1989